Effectiveness of Digoxin in Reducing One-Year Mortality in Chronic Heart Failure in the Digitalis Investigation Group Trial

Post hoc analyses of the Digitalis Investigation Group (DIG) trial indicate that digoxin at low (0.5–0.9 ng/ml) serum digoxin concentration (SDC) reduces mortality, which is eliminated at higher (≥1 ng/ml) SDC, and that low-dose (≤ 0.125 mg/day) digoxin predicts low SDC. In the DIG trial, ambulatory...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Ahmed, Ali, Waagstein, Finn, Pitt, Bertram, White, Michel, Zannad, Faiez, Young, James B., Rahimtoola, Shahbudin H.
Format: Artigo
Langue:Inglês
Publié: 2008
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2900803/
https://ncbi.nlm.nih.gov/pubmed/19101235
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjcard.2008.06.068
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires